价格

CAR T-cell therapy 3

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

ANTI-CD22 SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC CONSTRUCTS
EP 4188952 A4申请人: NAT RES COUNCIL CANADA优先权: 2020
CN
EP
US
WO
5 件公开
METHOD TO GENERATE IMPROVING CAR-T CELLS
EP 4598565 A1申请人: INST NAT SANTE RECH MED优先权: 2022
EP
US
WO
3 件公开
METHOD FOR PREPARING CRYOPRESERVED CELLS INTO CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS
WO 2025130072 A1申请人: SHANGHAI CELL THERAPY GROUP CO LTD优先权: 2023
CN
WO
3 件公开
TREATING CANCER
- EP 4612278 A1
  申请人: MAYO FOUND MEDICAL EDUCATION & RES优先权: 2022
  EP
  WO
  2 件公开
- WO 2025231208 A1
  申请人: MAYO FOUND MEDICAL EDUCATION & RES优先权: 2024
  WO
CD20 therapy, CD22 therapy and combination therapy with CD19 chimeric antigen receptor (CAR) expressing cells
CN 114958764 A申请人: NOVARTIS AG优先权: 2015
CN
2 件公开
Reagent for enhancing capacity of homing CAR-T cell to solid tumor tissue
CN 109593726 A申请人: CHONGQING PREC BIOTECH CO LTD优先权: 2018
CN
2 件公开
Immune regulation metabolite screening by immune system humanized mouse intestinal flora disturbance model
CN 120666006 A申请人: WUXI NANJING UNIV XISHAN APPLIED BIO TECH INSTITUTE优先权: 2025
CN
2 件公开
Epithelial growth factor receptor immunogen polypeptide and use thereof
CN 106366180 A申请人: SUZHOU PULUODA BIOLOGICAL SCIENCE AND TECH CO LTD优先权: 2016
CN
CEA (carcino-embryonic antigen) immunogenic polypeptide and application thereof
CN 106279402 A申请人: SUZHOU PULUODA BIOLOGICAL SCIENCE AND TECH CO LTD优先权: 2016
CN
UDP glycosyl transferase immunogen polypeptide and applications thereof
CN 106367406 A申请人: SUZHOU PULUODA BIOLOGICAL SCIENCE AND TECH CO LTD优先权: 2016
CN

药物

CAR T-cell therapy 3

专利

TREATING CANCER